Clinical trial
A Multicenter Collaborative Clinical Study of Umbilical Cord Blood Combined With Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of Bone Marrow Failure Disorders
NCT05794425 is registered in ClinicalTrials.gov with Shandong Qilu Stem Cells Engineering Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Collaborative Clinical Study of Umbilical Cord Blood Combined With Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of Bone Marrow Failure Disorders
- Lead sponsor
- Shandong Qilu Stem Cells Engineering Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- August 1, 2023
- Completion date
- April 30, 2026
- Enrollment
- 100 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.